Publications 2025

Anthi AK, Kolderup A, Vaage EB, Bern M, Benjakul S, Tjärnhage E, Ruso-Julve F, Jensen KR, Lode HE, Vaysburd M, Nilsen J, Herigstad ML, Sakya SA, Tietze L, Pilati D, Nyquist-Andersen M, Dürkoop M, Gjølberg TT, Peng L, Foss S, Moe MC, Low BE, Wiles MV, Nemazee D, Jahnsen FL et al. (2025)
An intranasal subunit vaccine induces protective systemic and mucosal antibody immunity against respiratory viruses in mouse models
16 (1), 3999
DOI 10.1038/s41467-025-59353-6, PubMed 40312392

Publications 2024

Alirezaylavasani A, Egner IM, Dahl B, Chopra A, de Matos Kasahara T, Goll GL, Jahnsen J, Grødeland G, Vaage JT, Lund-Johansen F, Holter JC, Halvorsen B, Jørgensen KK, Munthe LA, Kared H (2024)
Deficient SARS-CoV-2 hybrid immunity during inflammatory bowel disease
271, 110404
DOI 10.1016/j.clim.2024.110404, PubMed 39645159

Alirezaylavasani A, Skeie LG, Egner IM, Chopra A, Dahl TB, Prebensen C, Vaage JT, Halvorsen B, Lund-Johansen F, Tonby K, Reikvam DH, Stiksrud B, Holter JC, Dyrhol-Riise AM, Munthe LA, Kared H (2024)
Vaccine responses and hybrid immunity in people living with HIV after SARS-CoV-2 breakthrough infections
9 (1), 185
DOI 10.1038/s41541-024-00972-3, PubMed 39384763

Gainullin M, Federico L, Røkke Osen J, Chaban V, Kared H, Alirezaylavasani A, Lund-Johansen F, Wildendahl G, Jacobsen JA, Sarwar Anjum H, Stratford R, Tennøe S, Malone B, Clancy T, Vaage JT, Henriksen K, Wüsthoff L, Munthe LA (2024)
People who use drugs show no increase in pre-existing T-cell cross-reactivity toward SARS-CoV-2 but develop a normal polyfunctional T-cell response after standard mRNA vaccination
14, 1235210
DOI 10.3389/fimmu.2023.1235210, PubMed 38299149

Kared H, Jyssum I, Alirezaylavasani A, Egner IM, The Tran T, Tietze L, Lund KP, Tveter AT, Provan SA, Ørbo H, Haavardsholm EA, Vaage JT, Jørgensen K, Syversen SW, Lund-Johansen F, Goll GL, Munthe LA (2024)
Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study
15, 1296273
DOI 10.3389/fimmu.2024.1296273, PubMed 38455062

Tunheim G, Fossum E, Robertson AH, Rø GØI, Chopra A, Vaage JT, Vikse EL, Kran AB, Magnus P, Trogstad L, Mjaaland S, Hungnes O, Lund-Johansen F (2024)
Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary Omicron infection in children and hybrid immunity in adults
24 (1), 841
DOI 10.1186/s12879-024-09670-w, PubMed 39164637

Wolf AS, Bjørlykke KH, Ørbo HS, Bhandari S, Solum G, Kjønstad IF, Jyssum I, Nygaard UC, Kristoffersen AB, Christensen IE, Josefsson SE, Lund KP, Chopra A, Osen JR, Chaban V, Tveter AT, Sexton J, Kvien TK, Jahnsen J, Haavardsholm EA, Grødeland G, Vaage JT, Provan SA, Kared H, Lund-Johansen F et al. (2024)
T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study
108, 105317
DOI 10.1016/j.ebiom.2024.105317, PubMed 39260039

Wüsthoff LEC, Lund-Johansen F, Henriksen K, Wildendahl G, Jacobsen JA, Gomes L, Anjum HS, Barlinn R, Kran AB, Munthe LA, Vaage JT (2024)
Seroprevalence of SARS-CoV-2 and humoral immune responses to COVID-19 mRNA vaccines among people who use drugs - in the light of tailored mitigating strategies
21 (1), 120
DOI 10.1186/s12954-024-01023-9, PubMed 38890611

Ørbo HS, Bjørlykke KH, Sexton J, Jyssum I, Tveter AT, Christensen IE, Mjaaland S, Kvien TK, Grødeland G, Kro GB, Jahnsen J, Haavardsholm EA, Munthe LA, Provan SA, Vaage JT, Goll GL, Jørgensen KK, Syversen SW (2024)
Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study
10 (2)
DOI 10.1136/rmdopen-2023-003545, PubMed 38599653

Ørbo HS, de Matos Kasahara T, Wolf AS, Bjørlykke KH, Sexton J, Jyssum I, Tveter AT, Solum G, Kjønstad IF, Bhandari S, Christensen IE, Kvien TK, Lind A, Kared H, Jahnsen J, Haavardsholm EA, Munthe LA, Provan SA, Vaage JT, Mjaaland S, Syversen SW, Jørgensen KK, Grødeland G, Goll GL (2024)
Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study
48, 101121
DOI 10.1016/j.lanepe.2024.101121, PubMed 39624496

Publications 2023

Federico L, Tvedt THA, Gainullin M, Osen JR, Chaban V, Lund KP, Tietze L, Tran TT, Lund-Johansen F, Kared H, Lind A, Vaage JT, Stratford R, Tennøe S, Malone B, Clancy T, Myhre AEL, Gedde-Dahl T, Munthe LA (2023)
Robust spike-specific CD4⁺ and CD8⁺ T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort study
14, 1210899
DOI 10.3389/fimmu.2023.1210899, PubMed 37503339

Hovd M, Åsberg A, Munthe LA, Heldal K, Reisæter AV, Vaage JT, Lund-Johansen F, Midtvedt K (2023)
Humoral vaccine response and breakthrough infections in kidney transplant recipients during the COVID-19 pandemic: a nationwide cohort study
60, 102035
DOI 10.1016/j.eclinm.2023.102035, PubMed 37362086

Kared H, Alirezaylavasani A, Lund KP, Chopra A, Tietze L, de Matos Kasahara T, Goll GL, Grødeland G, Kaarbø M, Reisæter AV, Hovd M, Heldal K, Vaage JT, Lund-Johansen F, Midtvedt K, Åsberg A, Munthe LA (2023)
Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipients
97, 104833
DOI 10.1016/j.ebiom.2023.104833, PubMed 37844534

Meyer S, Blaas I, Bollineni RC, Delic-Sarac M, Tran TT, Knetter C, Dai KZ, Madssen TS, Vaage JT, Gustavsen A, Yang W, Nissen-Meyer LSH, Douvlataniotis K, Laos M, Nielsen MM, Thiede B, Søraas A, Lund-Johansen F, Rustad EH, Olweus J (2023)
Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants
42 (1), 111995
DOI 10.1016/j.celrep.2023.111995, PubMed 36656713

Nissen-Meyer LSH, Macpherson ME, Skeie LG, Hvalryg M, Llohn AH, Steinsvåg TT, Fenstad MH, Tveita A, Kristoffersen EK, Sundic T, Lund-Johansen F, Vaage JT, Flesland Ø, Dyrhol-Riise AM, Holter JC, Hervig TA, Fevang B (2023)
COVID-19 patients treated with convalescent plasma
143 (11)
DOI 10.4045/tidsskr.22.0577, PubMed 37589359

Nissen-Meyer LSH, Steinsvåg TT, Fenstad MH, Sørvoll IH, Hvalryg M, Titze TL, Magnussen K, Kristoffersen G, Johnsen KMN, Llohn AH, Hermundstad B, Høiback LS, Haugen M, Kristoffersen EK, Boulland LML, Kran AB, Lund-Johansen F, Vaage JT, Flesland Ø, Hervig TA (2023)
Convalescent plasma from Norwegian blood donors to treat COVID-19
143 (11)
DOI 10.4045/tidsskr.22.0180, PubMed 37589362

Tran TT, Vaage EB, Mehta A, Chopra A, Tietze L, Kolderup A, Anthi A, König M, Nygaard G, Lind A, Müller F, Nissen-Meyer LS, Magnus P, Trogstad L, Mjaaland S, Søraas A, Midtvedt K, Åsberg A, Barratt-Due A, Medhus AW, Høivik ML, Lundin K, Karlsen RF, Dahle R, Danielsson K et al. (2023)
Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
8 (1), 4
DOI 10.1038/s41541-023-00600-6, PubMed 36697432

Åsberg A, Hovd M, Kjellevold SA, Stenehjem AE, Wien TN, Broch LU, Reier-Nielsen M, Qvale TH, Marti HP, Heldal K, Bitter J, Hagelsteen Kvien E, Vaage JT, Lund-Johansen F, Midtvedt K (2023)
Humoral Response After 6 or More Successive Doses of SARS-CoV-2 mRNA Vaccines in Kidney Transplant Recipients-Should We Keep Vaccinating?
107 (10), e279-e280
DOI 10.1097/TP.0000000000004732, PubMed 37496122

Publications 2022

Bjørlykke KH, Ørbo HS, Tveter AT, Jyssum I, Sexton J, Tran TT, Christensen IE, Kro GB, Kvien TK, Jahnsen J, Munthe LA, Chopra A, Warren DJ, Mjaaland S, Haavardsholm EA, Grødeland G, Provan SA, Vaage JT, Syversen SW, Goll GL, Jørgensen KK (2022)
Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study
5 (1), e36-e46
DOI 10.1016/S2665-9913(22)00330-7, PubMed 36415604

Christensen IE, Jyssum I, Tveter AT, Sexton J, Tran TT, Mjaaland S, Kro GB, Kvien TK, Warren DJ, Jahnsen J, Munthe LA, Haavardsholm EA, Vaage JT, Grødeland G, Lund-Johansen F, Jørgensen KK, Syversen SW, Goll GL, Provan SA (2022)
The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls-a prospective cohort study
20 (1), 378
DOI 10.1186/s12916-022-02587-8, PubMed 36199139

Ibsen JH, Chopra A, Vaage EB, Vaage JT, Lund-Johansen F, Lundin KEA (2022)
Immune responses to SARS-CoV-2 vaccines in celiac disease
58 (2), 142-147
DOI 10.1080/00365521.2022.2114809, PubMed 36049123

Kared H, Wolf AS, Alirezaylavasani A, Ravussin A, Solum G, Tran TT, Lund-Johansen F, Vaage JT, Nissen-Meyer LS, Nygaard UC, Hungnes O, Robertson AH, Næss LM, Trogstad L, Magnus P, Munthe LA, Mjaaland S (2022)
Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults
13 (1), 4165
DOI 10.1038/s41467-022-31888-y, PubMed 35851055

König M, Torgauten HM, Tran TT, Holmøy T, Vaage JT, Lund-Johansen F, Nygaard GO (2022)
Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination
79 (3), 307-309
DOI 10.1001/jamaneurol.2021.5109, PubMed 35072702

Midtvedt K, Vaage JT, Heldal K, Munthe LA, Lund-Johansen F, Åsberg A (2022)
Fourth dose of the SARS-CoV-2 vaccine in kidney transplant recipients with previously impaired humoral antibody response
22 (11), 2704-2706
DOI 10.1111/ajt.17091, PubMed 35533010

Nissen-Meyer LSH, Hervig T, Fevang B, Norheim G, Kran AB, Vaage JT, Flesland Ø (2022)
COVID-19 convalescent plasma from Norwegian blood donors
142 (9)
DOI 10.4045/tidsskr.22.0057, PubMed 35699539

Riise J, Meyer S, Blaas I, Chopra A, Tran TT, Delic-Sarac M, Hestdalen ML, Brodin E, Rustad EH, Dai KZ, Vaage JT, Nissen-Meyer LSH, Sund F, Wader KF, Bjornevik AT, Meyer PA, Nygaard GO, König M, Smeland S, Lund-Johansen F, Olweus J, Kolstad A (2022)
Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination
197 (6), 697-708
DOI 10.1111/bjh.18149, PubMed 35254660

Syversen SW, Jyssum I, Tveter AT, Sexton J, Christensen IE, Tran TT, Bjørlykke KH, Mjaaland S, Warren DJ, Kvien TK, Chopra A, Kro GB, Jahnsen J, Munthe LA, Haavardsholm EA, Grødeland G, Vaage JT, Provan SA, Jørgensen KK, Goll GL (2022)
Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy
8 (2)
DOI 10.1136/rmdopen-2022-002417, PubMed 36328399

Syversen SW, Jyssum I, Tveter AT, Tran TT, Sexton J, Provan SA, Mjaaland S, Warren DJ, Kvien TK, Grødeland G, Nissen-Meyer LSH, Ricanek P, Chopra A, Andersson AM, Kro GB, Jahnsen J, Munthe LA, Haavardsholm EA, Vaage JT, Lund-Johansen F, Jørgensen KK, Goll GL (2022)
Immunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy
74 (8), 1321-1332
DOI 10.1002/art.42153, PubMed 35507355

Søraas A, Grødeland G, Granerud BK, Ueland T, Lind A, Fevang B, Murphy SL, Huse C, Nygaard AB, Steffensen AK, Al-Baldawi H, Holberg-Petersen M, Andresen LL, Ågnes C, Ranheim T, Schanke Y, Istre M, Dahl JA, Chopra A, Dudman S, Kaarbø M, Andersen JT, Vaage EB, Tran TT, Vaage JT et al. (2022)
Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
13, 964525
DOI 10.3389/fimmu.2022.964525, PubMed 36159859

Tran TT, Vaage EB, Mehta A, Chopra A, Tietze L, Kolderup A, Anthi A, König M, Nygaard G, Lind A, Müller F, Nissen-Meyer LS, Magnus P, Trogstad L, Mjaaland S, Søraas A, Midtvedt K, Åsberg A, Barratt-Due A, Medhus AW, Høivik ML, Lundin K, Karlsen RF, Dahle R, Danielsson K et al. (2022)
Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
7 (1), 174
DOI 10.1038/s41541-022-00586-7, PubMed 36585405

Tunheim G, Rø GØI, Chopra A, Aase A, Kran AB, Vaage JT, Lund-Johansen F, Hungnes O (2022)
Prevalence of antibodies against SARS-CoV-2 in the Norwegian population, August 2021
16 (6), 1004-1013
DOI 10.1111/irv.13024, PubMed 35770841

Publications 2021

Jyssum I, Kared H, Tran TT, Tveter AT, Provan SA, Sexton J, Jørgensen KK, Jahnsen J, Kro GB, Warren DJ, Vaage EB, Kvien TK, Nissen-Meyer LH, Anderson AM, Grødeland G, Haavardsholm EA, Vaage JT, Mjaaland S, Syversen SW, Lund-Johansen F, Munthe LA, Goll GL (2021)
Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study
4 (3), e177-e187
DOI 10.1016/S2665-9913(21)00394-5, PubMed 34977602

König M, Lorentzen ÅR, Torgauten HM, Tran TT, Schikora-Rustad S, Vaage EB, Mygland Å, Wergeland S, Aarseth J, Aaberge IAS, Torkildsen Ø, Holmøy T, Berge T, Myhr KM, Harbo HF, Andersen JT, Munthe LA, Søraas A, Celius EG, Vaage JT, Lund-Johansen F, Nygaard GO (2021)
Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations
94 (1), 19-22
DOI 10.1136/jnnp-2021-327612, PubMed 34670844

Lie BA, Viken MK, Egeland T, Undlien DE, Vaage JT (2021)
OBITUARY Erik Thorsby (1938-2021)
HLA, 98 (1), 3-4
DOI 10.1111/tan.14290

Tunheim G, Rø GØI, Tran T, Kran AB, Andersen JT, Vaage EB, Kolderup A, Vaage JT, Lund-Johansen F, Hungnes O (2021)
Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemic
16 (2), 204-212
DOI 10.1111/irv.12932, PubMed 34751488

Publications 2019

Kjeldsen-Kragh J, Titze TL, Lie BA, Vaage JT, Kjær M (2019)
HLA-DRB3*01:01 exhibits a dose-dependent impact on HPA-1a antibody levels in HPA-1a-immunized women
3 (7), 945-951
DOI 10.1182/bloodadvances.2019032227, PubMed 30923048

Publications 2018

Dai KZ, Ryan JC, Naper C, Vaage JT (2018)
Identification of MHC Class Ib Ligands for Stimulatory and Inhibitory Ly49 Receptors and Induction of Potent NK Cell Alloresponses in Rats
200 (8), 2847-2859
DOI 10.4049/jimmunol.1701464, PubMed 29531166

Publications 2017

Sudworth A, Vaage JT, Inngjerdingen M, Kveberg L (2017)
Frontline Science: A hyporesponsive subset of rat NK cells negative for Ly49s3 and NKR-P1B are precursors to the functionally mature NKR-P1B⁺ subset
102 (6), 1289-1298
DOI 10.1189/jlb.1HI0517-177RR, PubMed 28747319

Publications 2016

Sudworth A, Dai KZ, Vaage JT, Kveberg L (2016)
Degranulation Response in Cytotoxic Rat Lymphocytes Measured with a Novel CD107a Antibody
7, 572
DOI 10.3389/fimmu.2016.00572, PubMed 28003815

Publications 2014

Kveberg L, Sudworth A, Todros-Dawda I, Inngjerdingen M, Vaage JT (2014)
Functional characterization of a conserved pair of NKR-P1 receptors expressed by NK cells and T lymphocytes in liver and gut
45 (2), 501-12
DOI 10.1002/eji.201444710, PubMed 25382546

Leibelt S, Friede ME, Rohe C, Gütle D, Rutkowski E, Weigert A, Kveberg L, Vaage JT, Hornef MW, Steinle A (2014)
Dedicated immunosensing of the mouse intestinal epithelium facilitated by a pair of genetically coupled lectin-like receptors
8 (2), 232-42
DOI 10.1038/mi.2014.60, PubMed 24985083

Smelt MJ, Faas MM, de Haan BJ, de Haan A, Vaage JT, de Vos P (2014)
The Role of Alloresponsive Ly49(+) NK Cells in Rat Islet Allograft Failure in the Presence and Absence of Cytomegalovirus
Cell Transplant., 23 (11), 1381-1394
DOI 10.3727/096368913X670930

Todros-Dawda I, Kveberg L, Vaage JT, Inngjerdingen M (2014)
The tetraspanin CD53 modulates responses from activating NK cell receptors, promoting LFA-1 activation and dampening NK cell effector functions
9 (5), e97844
DOI 10.1371/journal.pone.0097844, PubMed 24832104

Publications 2012

Daws MR, Dai KZ, Zinöcker S, Naper C, Kveberg L, Hedrich HJ, Rolstad B, Vaage JT (2012)
Identification of an MHC class I ligand for the single member of a killer cell lectin-like receptor family, KLRH1
189 (11), 5178-84
DOI 10.4049/jimmunol.1201983, PubMed 23100519

Inngjerdingen M, Kveberg L, Vaage JT (2012)
A novel NKR-P1B(bright) NK cell subset expresses an activated CD25(+)CX(3)CR1(+)CD62L(-)CD11b(-)CD27(-) phenotype and is prevalent in blood, liver, and gut-associated lymphoid organs of rats
188 (6), 2499-508
DOI 10.4049/jimmunol.1003939, PubMed 22308308

Zinöcker S, Vaage JT (2012)
Rat mesenchymal stromal cells inhibit T cell proliferation but not cytokine production through inducible nitric oxide synthase
3, 62
DOI 10.3389/fimmu.2012.00062, PubMed 22566943

Zinöcker S, Wang MY, Rolstad B, Vaage JT (2012)
Mesenchymal stromal cells fail to alleviate experimental graft-versus-host disease in rats transplanted with major histocompatibility complex-mismatched bone marrow
76 (5), 464-70
DOI 10.1111/j.1365-3083.2012.02758.x, PubMed 22803811

Publications 2011

Fossum S, Saether PC, Vaage JT, Daws MR, Dissen E (2011)
Paired opposing leukocyte receptors recognizing rapidly evolving ligands are subject to homogenization of their ligand binding domains
Immunogenetics, 63 (12), 809-820
DOI 10.1007/s00251-011-0553-5

Inngjerdingen M, Kveberg L, Naper C, Vaage JT (2011)
Natural killer cell subsets in man and rodents
78 (2), 81-8
DOI 10.1111/j.1399-0039.2011.01714.x, PubMed 21726202

Kveberg L, Dai KZ, Inngjerdingen M, Brooks CG, Fossum S, Vaage JT (2011)
Phylogenetic and functional conservation of the NKR-P1F and NKR-P1G receptors in rat and mouse
63 (7), 429-36
DOI 10.1007/s00251-011-0520-1, PubMed 21409442

Shegarfi H, Dai KZ, Daws MR, Ryan JC, Vaage JT, Rolstad B, Naper C (2011)
The rat NK cell receptors Ly49s4 and Ly49i4 recognize nonclassical MHC-I molecules on Listeria monocytogenes-infected macrophages
89 (4), 617-23
DOI 10.1189/jlb.1010593, PubMed 21248147

Zinöcker S, Wang MY, Gaustad P, Kvalheim G, Rolstad B, Vaage JT (2011)
Mycoplasma contamination revisited: mesenchymal stromal cells harboring Mycoplasma hyorhinis potently inhibit lymphocyte proliferation in vitro
6 (1), e16005
DOI 10.1371/journal.pone.0016005, PubMed 21264307

Publications 2010

Kveberg L, Jiménez-Royo P, Naper C, Rolstad B, Butcher GW, Vaage JT, Inngjerdingen M (2010)
Two complementary rat NK cell subsets, Ly49s3+ and NKR-P1B+, differ in phenotypic characteristics and responsiveness to cytokines
88 (1), 87-93
DOI 10.1189/jlb.0110039, PubMed 20395458

Naper C, Kveberg L, Engh E, Nestvold J, Rolstad B, Vaage JT (2010)
Partial NK cell tolerance induced by radioresistant host cells in rats transplanted with MHC-mismatched bone marrow
22 (12), 973-80
DOI 10.1093/intimm/dxq452, PubMed 21118904

Shegarfi H, Dai KZ, Inngjerdingen M, Ryan JC, Vaage JT, Rolstad B, Naper C (2010)
The activating rat Ly49s5 receptor responds to increased levels of MHC class Ib molecules on Listeria monocytogenes-infected enteric epithelial cells
40 (12), 3535-43
DOI 10.1002/eji.201040651, PubMed 21108473

Publications 2009

Kveberg L, Dai KZ, Westgaard IH, Daws MR, Fossum S, Naper C, Vaage JT (2009)
Two major groups of rat NKR-P1 receptors can be distinguished based on chromosomal localization, phylogenetic analysis and Clr ligand binding
39 (2), 541-51
DOI 10.1002/eji.200838891, PubMed 19130483

Publications 2008

Nestvold JM, Omdal BK, Dai KZ, Martens A, Benestad HB, Vaage JT, Rolstad B (2008)
A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease
85 (1), 102-11
DOI 10.1097/01.tp.0000296856.53493.1f, PubMed 18192919

Publications 2006

Kveberg L, Bäck CJ, Dai KZ, Inngjerdingen M, Rolstad B, Ryan JC, Vaage JT, Naper C (2006)
The novel inhibitory NKR-P1C receptor and Ly49s3 identify two complementary, functionally distinct NK cell subsets in rats
176 (7), 4133-40
DOI 10.4049/jimmunol.176.7.4133, PubMed 16547249

Kveberg L, Dai KZ, Dissen E, Ryan JC, Rolstad B, Vaage JT, Naper C (2006)
Strain-dependent expression of four structurally related rat Ly49 receptors; correlation with NK gene complex haplotype and NK alloreactivity
58 (11), 905-16
DOI 10.1007/s00251-006-0154-x, PubMed 17028855

Sollid LM, Vaage JT (2006)
Cross-dressing T cells go wild
12 (6), 611-2
DOI 10.1038/nm0606-611, PubMed 16761002

Publications 2005

Naper C, Dai KZ, Kveberg L, Rolstad B, Niemi EC, Vaage JT, Ryan JC (2005)
Two structurally related rat Ly49 receptors with opposing functions (Ly49 stimulatory receptor 5 and Ly49 inhibitory receptor 5) recognize nonclassical MHC class Ib-encoded target ligands
174 (5), 2702-11
DOI 10.4049/jimmunol.174.5.2702, PubMed 15728478

Nylenna O, Naper C, Vaage JT, Woon PY, Gauguier D, Dissen E, Ryan JC, Fossum S (2005)
The genes and gene organization of the Ly49 region of the rat natural killer cell gene complex
35 (1), 261-72
DOI 10.1002/eji.200425429, PubMed 15593300

Publications 2004

Helgeland L, Dissen E, Dai KZ, Midtvedt T, Brandtzaeg P, Vaage JT (2004)
Microbial colonization induces oligoclonal expansions of intraepithelial CD8 T cells in the gut
34 (12), 3389-400
DOI 10.1002/eji.200425122, PubMed 15517613

Nejad S, Bryceson Y, Dissen E, Sundvold-Gjerstad V, Naper C, Rolstad B, Spurkland A, Vaage JT (2004)
cDNA cloning of a rat orthologue of SH2D2A encoding T-cell-specific adaptor protein (TSAd): expression in T and NK cells
56 (5), 338-42
DOI 10.1007/s00251-004-0695-9, PubMed 15300336

Publications 2002

Naper C, Hayashi S, Kveberg L, Niemi EC, Lanier LL, Vaage JT, Ryan JC (2002)
Ly-49s3 is a promiscuous activating rat NK cell receptor for nonclassical MHC class I-encoded target ligands
169 (1), 22-30
DOI 10.4049/jimmunol.169.1.22, PubMed 12077224

Naper C, Hayashi S, Løvik G, Kveberg L, Niemi EC, Rolstad B, Dissen E, Ryan JC, Vaage JT (2002)
Characterization of a novel killer cell lectin-like receptor (KLRH1) expressed by alloreactive rat NK cells
168 (10), 5147-54
DOI 10.4049/jimmunol.168.10.5147, PubMed 11994469

Publications 2001

Løvik G, Vaage JT, Rolstad B, Naper C (2001)
The effect of in vivo depletion of NKR-P1+ or CD8+ lymphocytes on the acute rejection of allogeneic lymphocytes (ALC) in the rat
54 (4), 341-7
DOI 10.1046/j.1365-3083.2001.00979.x, PubMed 11555400

Rolstad B, Naper C, Løvik G, Vaage JT, Ryan JC, Bäckman-Petersson E, Kirsch RD, Butcher GW (2001)
Rat natural killer cell receptor systems and recognition of MHC class I molecules
181, 149-57
DOI 10.1034/j.1600-065x.2001.1810112.x, PubMed 11513136

Torgersen KM, Vaage JT, Rolstad B, Taskén K (2001)
A soluble LAT deletion mutant inhibits T-cell activation: reduced recruitment of signalling molecules to glycolipid-enriched microdomains
13 (3), 213-20
DOI 10.1016/s0898-6568(01)00131-0, PubMed 11282460

Publications 1999

Helgeland L, Johansen FE, Utgaard JO, Vaage JT, Brandtzaeg P (1999)
Oligoclonality of rat intestinal intraepithelial T lymphocytes: overlapping TCR beta-chain repertoires in the CD4 single-positive and CD4/CD8 double-positive subsets
162 (5), 2683-92
PubMed 10072512

Publications 1998

Weber JR, Orstavik S, Torgersen KM, Danbolt NC, Berg SF, Ryan JC, Taskén K, Imboden JB, Vaage JT (1998)
Molecular cloning of the cDNA encoding pp36, a tyrosine-phosphorylated adaptor protein selectively expressed by T cells and natural killer cells
187 (7), 1157-61
DOI 10.1084/jem.187.7.1157, PubMed 9529333

Publications 1997

Helgeland L, Brandtzaeg P, Rolstad B, Vaage JT (1997)
Sequential development of intraepithelial gamma delta and alpha beta T lymphocytes expressing CD8 alpha beta in neonatal rat intestine: requirement for the thymus
92 (4), 447-56
DOI 10.1046/j.1365-2567.1997.00379.x, PubMed 9497485

Helgeland L, Vaage JT, Rolstad B, Halstensen TS, Midtvedt T, Brandtzaeg P (1997)
Regional phenotypic specialization of intraepithelial lymphocytes in the rat intestine does not depend on microbial colonization
46 (4), 349-57
DOI 10.1046/j.1365-3083.1997.d01-133.x, PubMed 9350285

Torgersen KM, Vaage JT, Levy FO, Hansson V, Rolstad B, Taskén K (1997)
Selective activation of cAMP-dependent protein kinase type I inhibits rat natural killer cell cytotoxicity
272 (9), 5495-500
DOI 10.1074/jbc.272.9.5495, PubMed 9038153

Publications 1996

Helgeland L, Vaage JT, Rolstad B, Midtvedt T, Brandtzaeg P (1996)
Microbial colonization influences composition and T-cell receptor V beta repertoire of intraepithelial lymphocytes in rat intestine
89 (4), 494-501
DOI 10.1046/j.1365-2567.1996.d01-783.x, PubMed 9014812

Publications 1995

Vaage JT (1995)
Biological properties of rat large granular lymphocytes: MHC control of NK allorecognition
Immunobiological laboratory, Departemnt [i.e. Department]of Anatomy, Institute of Basic Medical Sciences, University of Oslo, [Oslo], 1 b. (flere pag.)
BIBSYS 95180586x, ISBN 82-91061-64-5

Publications 1990

Dissen E, Vaage JT, Taskén K, Jahnsen T, Rolstad B, Fossum S (1990)
Alloreactive lymphokine-activated killer cells from athymic nude rats do not express CD3-associated alpha/beta or gamma/delta T cell receptors
2 (5), 453-60
DOI 10.1093/intimm/2.5.453, PubMed 2150758